This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Orexigen Therapeutics Inc (OREX)

NASDAQ: Health Care

Get a 5-page Ratings Report on (OREX) now
$5.54-0.16 | -2.81%
04/23/14 - 4:00 PM ET
  • Latest Dividend: N/A
  • Latest Dividend Yield: N/A
  • Dividend Ex-Date: N/A
  • Price Earnings Ratio: -9.4375
  • Price Earnings Comparisons:
    OREX Sector Avg. S&P 500
    -9.44 0.00 29.20
  • Price Performance History
    (% change):
    3 Mo 1 Yr 3 Yr
    -15.05% -9.52% 79.81%
  • GROWTH 12 Mo 3 Yr CAGR
    Revenue 0.00 1.78 0.40
    Net Income 0.00 0.50 0.00
    EPS 0.00 -0.27 0.00
  • Earnings for OREX:
    EBITDA -77,198,000
    REVENUE 3,428,000
Average Earnings Estimates
Qtr (03/14) Qtr (06/14) FY (12/14) FY (12/15)
Average Estimate $-0.20 $0.13 $-0.07 $-0.08
Number of Analysts 4 3 6 5
High Estimate $-0.18 $0.79 $0.76 $0.12
Low Estimate $-0.21 $-0.21 $-0.71 $-0.25
Prior Year $-0.21 $-0.19 $-0.80 $-0.07
Growth Rate (Year over Year) 7.14% 168.42% 90.63% -1.33%
(OREX) News

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASDAQ 4,126.9670 -34.4910 -0.83%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs